Chinook Therapeutics Inc. (KDNY)
NASDAQ: KDNY
· Real-Time Price · USD
40.39
0.09 (0.22%)
At close: Aug 10, 2023, 10:00 PM
Chinook Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -245.65M | -216.36M | -187.87M | -117.77M | -92.48M | -97.41M | -102.94M | -153.37M | -148.52M | -113.69M |
Depreciation & Amortization | 5.76M | 5.11M | 5.1M | 5.07M | 4.92M | 4.82M | 4.75M | 1.86M | 3.65M | 2.55M |
Stock-Based Compensation | 28.13M | 23.7M | 20.05M | 17.77M | 15.74M | 14.58M | 12.79M | 6.28M | 9.29M | 5.99M |
Other Working Capital | 931K | 16.26M | 8.89M | 4.42M | 672K | -7.46M | -610K | 3.6M | -17.86M | -11.66M |
Other Non-Cash Items | 24.19M | 22.37M | 20.23M | -20.88M | -28.23M | -16.96M | -14.32M | 46.38M | 45.88M | 33.05M |
Deferred Income Tax | 1.01M | 4.34M | 5.76M | 4.71M | 4.25M | -3.73M | -5.14M | -10.44M | -9.38M | -1.41M |
Change in Working Capital | 12.57M | 17.41M | 19.24M | 7.93M | -6.76M | -8.67M | -5.86M | 7.51M | -12.44M | -6.34M |
Operating Cash Flow | -174M | -143.43M | -117.48M | -103.15M | -102.57M | -99.39M | -102.74M | -93.82M | -104.16M | -80.44M |
Capital Expenditures | -2.6M | -2.21M | -1.65M | -1.35M | -1.74M | -1.66M | -1.88M | -2.17M | -1.14M | -1.37M |
Cash Acquisitions | -298.34M | -298.34M | -200.84M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -238.58M | -284.29M | -299.18M | -337.55M | -279.23M | -277.72M | -232.34M | -6.08M | -121.92M | -50.25M |
Sales Maturities Of Investments | 330.96M | 274.51M | 200.84M | 158.69M | 111.18M | 103.33M | 121.31M | -48.01M | 125.61M | 93.82M |
Other Investing Acitivies | 298.34M | 298.34M | 200.84M | n/a | n/a | n/a | 267K | 74.81M | 75.33M | 75.33M |
Investing Cash Flow | 89.78M | -11.99M | -99.99M | -180.21M | -169.78M | -176.05M | -112.64M | 18.56M | 77.88M | 117.53M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 65.81M | 170.94M | 151.43M | 301.34M | 282.77M | 210.71M | 209.52M | 145.62M | 131.05M | 95.96M |
Financial Cash Flow | 65.81M | 170.94M | 151.43M | 301.34M | 282.77M | 210.71M | 209.52M | 160.07M | 145.5M | 110.41M |
Net Cash Flow | -18.78M | 14.99M | -66.29M | 17.55M | 10.46M | -64.27M | -5.7M | 36.28M | 119.49M | 147.72M |
Free Cash Flow | -176.6M | -145.63M | -119.13M | -104.5M | -104.31M | -101.04M | -104.62M | -95.98M | -105.3M | -81.81M |